Dupixent Lawsuit in Minnesota - Free Case Review

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Key Takeaway

Minnesota's 4-year statute of limitations for product liability — among the longest in the Midwest — gives Dupixent CTCL patients generous filing time. An estimated 46,000 Minnesotans have been prescribed Dupixent since 2017, with heavy prescribing through the Mayo Clinic (Rochester), the University of Minnesota Medical Center, and Allina Health in the Twin Cities. The Masonic Cancer Center at the University of Minnesota, an NCI-designated comprehensive cancer center, provides specialized cutaneous lymphoma diagnostic capabilities. The Mayo Clinic in Rochester — while not technically in the Twin Cities — is one of the world's premier diagnostic institutions and a natural referral destination for complex CTCL cases. Minnesota's educated, health-conscious population tends to produce jury pools that are attentive to scientific evidence and institutional accountability. The District of Minnesota in Minneapolis has managed pharmaceutical and medical device litigation with competence, and the state's strong plaintiff bar includes attorneys experienced in mass tort coordination.

Written By

People's Justice Legal Research Team

Statute of Limitations

Minnesota: 4 years for product liability (Minn. Stat. § 541.05(1)(5)). Discovery rule applies — the limitations period begins when the plaintiff discovers or should have discovered the injury and its connection to the product.

4 years from discovery of injury

Filing Venue

Where to File in Minnesota

Minnesota has a single federal judicial district — the District of Minnesota, headquartered in Minneapolis and St. Paul. Minnesota follows a modified comparative fault system (51 percent bar) and does not cap compensatory damages in product liability cases. The District of Minnesota has managed complex pharmaceutical litigation and benefits from the Twin Cities' large, educated population and experienced legal community.

Minnesota Data

Exposure in Minnesota

Source: IQVIA prescription data estimates

Source: Mayo Clinic

Source: Minn. Stat. § 541.05(1)(5)

FAQ

Frequently Asked Questions

See details below.

Back to Dupixent Lawsuit Lawsuit Overview